EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

Paola Anna Jablonska iD, Nuria Galán, Jennifer Barranco, Sergio Leon, Ramón Robledano, José Ignacio Echeveste, Alfonso Calvo iD, Javier Aristu iD, Diego Serrano iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paola Anna Jablonska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Brain Neoplasms, Radiosurgery, Radiation Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundació La Marató de TV3, Gobierno de Navarra (Proyecto Granate) and ISCIII, IASLC and Juan de la Cierva—Incorporacion.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain radiation necrosis (RN) is a subacute or late adverse event following radiotherapy, involving an exacerbated inflammatory response of the brain tissue. The risk of symptomatic RN associated with stereotactic radiosurgery (SRS) as part of the treatment of brain metastases (BMs) has been a subject of recent investigation. The activation of the signal transducer and activator of transcription 3 (STAT3) was shown in reactive astrocytes (RA) associated with BMs. Given that the pathophysiological mechanisms behind RN are not fully understood, we sought to investigate the role of STAT3 among other inflammatory markers in RN development. A mouse model of RN using clinical LINAC-based SRS was designed to induce brain necrosis with the administration of 50 Gy in a single fraction to the left hemisphere using a circular collimator of 5 mm diameter. Immunohistochemistry and multiplex staining for CD4, CD8, CD68, GFAP, and STAT3 were performed. For validation, eleven patients with BMs treated with SRS who developed symptomatic RN and required surgery were identified to perform staining for CD68, GFAP, and STAT3. In the mouse model, the RN and perinecrotic areas showed significantly higher staining for F4/80+ and GFAP+ cells, with a high infiltration of CD4 and CD8 T-lymphocytes, when compared to the non-irradiated cerebral hemisphere. A high number of GFAP+pSTAT3+ and F4/80+pSTAT3+ cells was found in the RN areas and the rest of the irradiated hemisphere. The analysis of human brain specimens showed that astrocytes and microglia were actively phosphorylating STAT3 in the areas of RN and gliosis. Phosphorylated STAT3 is highly expressed in the microglia and RA pertaining to the areas of brain RN. Targeting STAT3 via inhibition represents a promising strategy to ameliorate symptomatic RN in BM patients undergoing SRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorBrain NeoplasmsRadiosurgeryRadiation InjuriesAnimalsHumansMicePhosphorylationNecrosisFemaleMaleMiddle AgedAgedBrainAstrocytesDisease Models, Animal

Stichwörter der Autor:innen

animal modelbrain metastasesphospho-STAT3radiation necrosisstereotactic radiosurgery

Substanzen

STAT3 Transcription FactorSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
  • Department of Pathological Anatomy, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
  • CIBERONC, ISCIII, 28029 Madrid, Spain.
  • Department of Radiation Oncology and Proton Therapy Unit, Clinica Universidad de Navarra, 28027 Madrid, Spain.

ORCID-Profile: Paola Anna Jablonska, Alfonso Calvo, Javier Aristu, Diego Serrano

Förderung

  • Instituto de Salud Carlos III
  • Fundació La Marató de TV3, Gobierno de Navarra (Proyecto Granate) and ISCIII
  • IASLC and Juan de la Cierva—Incorporacion
  • CIBERONC, ISCIII

Zitieren

APA

Jablonska, P. A., Galán, N., Barranco, J., Leon, S., Robledano, R., Echeveste, J. I., Calvo, A., Aristu, J., & Serrano, D. (2023). Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814219

Vancouver

Jablonska PA, Galán N, Barranco J, Leon S, Robledano R, Echeveste JI, et al. Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814219

BibTeX
@article{Jablonska2023,
  author = {Jablonska, Paola Anna and Galán, Nuria and Barranco, Jennifer and Leon, Sergio and Robledano, Ramón and Echeveste, José Ignacio and Calvo, Alfonso and Aristu, Javier and Serrano, Diego},
  title = {Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814219}
}
Kostenlos starten →